Pyridine
Pyridinium refers to the cation [C5H5NH]+. Often present in oximes as in the first reactivator of OP inhibited cholinesterase Pralidoxime (2-PAM). These are charged oximes which poorly cross the blood brain barrier
| Reactivator name | Formula | Structure |
|---|---|---|
| LG-Cpd55 |
C16H25N5O4 |
|
| 6-Alkyl-3-Fluoro-2-pyridinaldoxime-12d |
C13H12FN3O |
|
| 4-methyl-3-nitrobenzamido-pentyl-PAM-7d |
C19H23N4O4 |
|
| K1374 |
C26H28N4O22+ |
|
| K1375 |
C17H22N4O32+ |
|
| Triazole-annulated-oxime-2A |
C19H22N5O |
|
| Triazole-annulated-oxime-14A |
C17H19N7O2 |
|
| 7-MEOTA-4-pyridinealdoxime |
C25H33BrN4O2 |
|
| Ortho-7 |
C19H26N4O2-2+ |
|
| K727 |
C24H22Br2N4O2 |
|
| benzyl-pyridinium-4-methyltrichloroacetimidate |
C15H14Cl3N2O |
|
| MF5 |
C14H10F5N2O+ |
|
| TAB2OH |
C10H15ClN2O2 |
|
| Tryptoline-hydroxy-pyridinaldoxime-3 |
C21H24N4O2 |
|
| Phenyltetrahydroisoquinoline-Pyridinaldoxime-1b |
C27H31N3O4 |
|
| Phenyltetrahydroisoquinoline-Pyridinaldoxime-1c |
C28H33N3O4 |
|
| Tryptoline-hydroxy-pyridinaldoxime-4 |
C22H26N4O2 |
|
| JR585 |
C16H25N3O2 |
|
| JR595 |
C14H21N3O3 |
|
| GM415 |
C22H29N3O4 |
|
| GM508 |
C30H39N4O4 |
|
| RM048 |
C15H23N3O3 |
|
| 2-PAM |
C7H9N2O |
|
| 3-PAM |
C7H9N2O |
|
| 4-PAM |
C7H9N2O |
|
| Benzyl-P2A |
C13H13ClN2O |
|
| Tacrine-pyridinealdoxime-1 |
C23H27N4O2 |
|
| Tacrine-pyridinealdoxime-2 |
C23H25ClN4O2 |
|
| pro-2PAM |
C7H11ClN2O |
|
| R665 |
C17H22I2N4O4 |
|